Following the Evolution of Cardiac Myosin Inhibition: Remodeling Clinical Workflows to Realize the Greatest Benefit in oHCM and Beyond
Join PeerView for a Clinical Consults session to explore how cardiac myosin inhibitors are changing clinical workflows, as viewed through the lens of patient case scenarios. No longer the new kid on the block, emerging long-term evidence demonstrates how cardiac myosin inhibitors improve key indicators of heart function in oHCM across patient subgroups, including their positive effects on cardiac remodeling. Register today to watch and learn from the experts leading the charge to realize the exceptional benefits of cardiac myosin inhibitors in oHCM, nHCM, and beyond!
Milind Desai, MD, MBA
Anjali Tiku Owens, MD
This CME/MOC/AAPA activity is provided by PVI, PeerView Institute for Medical Education.
This activity is supported through an educational grant from Bristol Myers Squibb.